B · Normal
On November 6th, Moderna's third-quarter earnings per share were 38 cents, and the market forecast was a loss of US$1.09 per share. Moderna expects full-year research and development expenses to be approximately US$2.7 billion, compared with previous expectations of approximately US$2.9 billion.
U.S. stock trends 🕐 2026-11-06 19:47
#U.S. stock trends #medicine #Pharmaceutical business
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On November 6, the US satellite communications company AST SpaceMobile stated th 11-06 20:34 On November 6, JPMorgan Chase raised the target price of ConocoPhillips from US$ 11-06 20:28 On November 6, Moderna’s pre-market gains expanded to 10%. 11-06 20:06 On November 6th, Nike's stock price fell 2.6% before the market opened, and Angp 11-06 20:03 On November 6, the stock price of American sports brand Under Armor fell 12% bef 11-06 20:00 [Under Armor’s second quarter revenue fell 7% year-on-year to US$1.242 billion, 11-06 20:00

Comments

0/500
Captcha (click to refresh)
No comments yet